곽성찬 교수
#유방외과
|
학력
2016 .03 ~ 2018 .02울산대학교 의학 박사
2011 .03 ~ 2013 .02울산대학교 의학 석사
2001 .03 ~ 2008 .02순천향대학교 의학 학사
2011 .03 ~ 2013 .02울산대학교 의학 석사
2001 .03 ~ 2008 .02순천향대학교 의학 학사
경력
2019 .03 ~ 현재서울아산병원 유방외과 진료전담교수 (입원전담의, Hospitalist)
2016 .05 ~ 2019 .02서울아산병원 유방외과 임상강사 (전임의, Fellow)
2014 .07 ~ 2016 .04국방부 의무실 외과 과장 (군의관)
2013 .12 ~ 2014 .06필리핀 재해복구 지원단(ARAW부대) 의무대 외과 진료1과장
2009 .03 ~ 2013 .02서울아산병원 외과 전공의 (Resident)
2008 .03 ~ 2009 .02순천향대학교부속 부천병원 인턴 (Intern)
2016 .05 ~ 2019 .02서울아산병원 유방외과 임상강사 (전임의, Fellow)
2014 .07 ~ 2016 .04국방부 의무실 외과 과장 (군의관)
2013 .12 ~ 2014 .06필리핀 재해복구 지원단(ARAW부대) 의무대 외과 진료1과장
2009 .03 ~ 2013 .02서울아산병원 외과 전공의 (Resident)
2008 .03 ~ 2009 .02순천향대학교부속 부천병원 인턴 (Intern)
논문
Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.
Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Clinical implication of HER2 status in hormone receptor positive pure mucinous breast cancer
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Chemotherapy in node-negative, hormone receptor positive mucinous breast cancer
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Chemotherapy in node-negative, hormone receptor positive mucinous breast cancer
영상자료
영상자료 내용이 없습니다.
발표자료
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Chemotherapy in node-negative, hormone receptor positive mucinous breast cancer
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Chemotherapy in node-negative, hormone receptor positive mucinous breast cancer